|
GPR89B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.758600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.700500E-03 |
| Normal-vs-Stage2 |
3.635500E-02 |
| Normal-vs-Stage3 |
6.104500E-03 |
| Normal-vs-Stage4 |
1.341980E-01 |
| Stage1-vs-Stage2 |
7.401000E-01 |
| Stage1-vs-Stage3 |
5.852600E-01 |
| Stage1-vs-Stage4 |
2.767800E-01 |
| Stage2-vs-Stage3 |
5.273000E-01 |
| Stage2-vs-Stage4 |
5.757200E-01 |
| Stage3-vs-Stage4 |
2.190200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.798600E-03 |
| Normal-vs-AfricanAmerican |
3.994000E-01 |
| Normal-vs-Asian |
2.459100E-03 |
| Caucasian-vs-AfricanAmerican |
9.430000E-02 |
| Caucasian-vs-Asian |
3.631600E-01 |
| AfricanAmerican-vs-Asian |
1.394250E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.022500E-03 |
| Normal-vs-Female |
1.011980E-02 |
| Male-vs-Female |
6.018000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.064700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.942700E-03 |
| Normal-vs-Age(61-80Yrs) |
8.375900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.252400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.451200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.211610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.540200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.165780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.455600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.388800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.896400E-01 |
| Classical-VS-Follicular |
6.987600E-01 |
| Classical-VS-Other |
5.296400E-01 |
| Classical-VS-Normal |
1.010030E-02 |
| Tall-VS-Follicular |
8.252000E-01 |
| Tall-VS-Other |
5.192600E-01 |
| Tall-VS-Normal |
1.637010E-01 |
| Follicular-VS-Other |
4.782400E-01 |
| Follicular-VS-Normal |
3.148000E-02 |
| Other-VS-Normal |
1.409050E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.007680E-02 |
| Normal-vs-N1 |
1.724230E-02 |
| N0-vs-N1 |
9.218600E-01 |
|
|
